Status and phase
Conditions
Treatments
About
Characterization of the influence of pregnenolone vs. placebo on subjective distress and autonomic functioning during cognitive-behavioral exposure therapy in patients with obsessive-compulsive disorder.
Full description
Main out-come parameters:
Inter-session habituation as per SUD (100 mm VAS), Y-BOCS
Secondary out-come parameter:
HF/LF of HRV, Salivary epinephrine
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
-OCD according to DSM-IV criteria.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Michael Kellner, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal